Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice

Journal of Experimental Medicine

Volumn 197, Issue 8, 2003, Pages 997-1005

  Yoshimoto, Tomohiro ^a,b   Min, Booki ^c   Sugimoto, Takaaki ^a,b   Hayashi, Nobuki ^a,b   Ishikawa, Yuriko ^a,b   Sasaki, Yuki ^a,b   Hata, Hitomi ^a,b   Takeda, Kazuyoshi ^d   Okumura, Ko ^d   Van Kaer, Luc ^e   Paul, William E ^c   Nakanishi, Kenji ^a,b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergy; CD40 ligand; CD4+ NK1.1+ T cells; IL 18R; Th2 cytokines

Indexed keywords

CD1D ANTIGEN; CD40 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 9; STAT6 PROTEIN;

ALLERGY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIGENS, CD1; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; FEMALE; IMMUNOGLOBULIN E; INTERLEUKIN-13; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-9; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18; TH2 CELLS;

EID: 0242516124     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021701     Document Type: Article

References (35)

1. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378:88-91.
2. Gu, Y., K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M.A. Fleming, N. Hayashi, K. Higashino, H. Okamura, K. Nakanishi, et al. 1997. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science. 275:206-209.
3. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S.B. Hartley, S. Menon, R. Kastelein, F. Bazan, et al. 1997. IGIF dose not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity. 7:571-581.
4. Yoshimoto, T., K. Takeda, T. Tanaka, K. Ohkusu, S. Kasiwamura, H. Okamura, S. Akira, and K. Nakanishi. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J. Immunol. 161:3400-3407.
5. Yoshimoto, T., H. Okamura, Y-I. Tagawa, Y. Iwakura, and K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. USA. 94: 3948-3953.
6. Dinarello, C.A., D. Novick, A.J. Puren, G. Fantuzzi, L. Shapiro, H. Muhl, D.Y. Yoon, L.L. Reznikov, S.H. Kim, and M. Rubinstein. 1998. Overview of interleukin-18: more than an interferon-γ inducing factor. J. Leukoc. Biol. 63:658-664.
7. Munder, M., M. Mallo, K. Eichmann, and M. Modolell. 1998. Murine macrophages secrete interferon γ upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187:2103-2108.
8. Fukao, T., S. Matsuda, and S. Koyasu. 2000. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-γ production by dendritic cells. J. Immunol. 164:64-71.
9. Yoshimoto, T., H. Tsutsui, K. Tominaga, K. Hoshino, H. Okamura, S. Akira, W.E. Paul, and K. Nakanishi. 1999. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc. Natl. Acad. Sci. USA. 96:13962-13966.
10. + T cells, IL-4 and STAT6. Nat. Immunol. 1:132-137.
11. Hoshino, T., R.H. Wiltrout, and H.A. Young. 1999. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J. Immunol. 162:5070-5077.
12. + T cells. Eur. J. Immunol. 30:1998-2006.
13. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:423-474.
14. Chikano, S., K. Sawada, T. Shimoyama, A. Sugihara, K. Sekikawa, N. Terada, K. Nakanishi, and H. Okamura. 2000. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner. Gut. 47:779-786.
15. Yamanaka, K., M. Tanaka, H. Tsutsui, T.S. Kupper, K. Asahi, H. Okamura, K. Nakanishi, M. Suzuki, N. Kayagaki, R.A. Black, et al. 2000. Skin-specific caspase-1 transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J. Immunol. 165:997-1003.
16. Konishi, H., H. Tsutsui, T. Murakami, S. Yumikura-Futatsugi, K. Yamanaka, M. Tanaka, Y. Iwakura, N. Suzuki, E.V. Fuchs, K. Takeda, et al. 2002. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc. Natl. Acad. Sci. USA. 99:11340-11345.
17. Bendelac, A., M.N. Rivera, S.-H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
18. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1626-1629.
19. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-1295.
20. H2 response and in immunoglobulin E production. Science. 270:1845-1847.
21. Singh, N., S. Hong, D.C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer. 1999. Activation of NK T cells by CD1d and α galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163:2373-2377.
22. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with α galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:2014-2025.
23. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
24. Hyodo, Y., K. Matsui, N. Hayashi, H. Tsutsui, S. Kashiwamura, H. Yamauchi, K. Hiroishi, K. Takeda, Y. Tagawa, Y. Iwakura, et al. 1999. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162:1662-1668.
25. Lyons, A.B., and C.R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods. 171:131-137.
26. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158:5112-5119.
27. Finkelman, F.D., J. Holmes, I.M. Katona, J.F. Urban, Jr., M.P. Beckmann, L.S. Park, K.A. Schooley, R.L. Coffman, T.R. Mosmann, and W.E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
28. Galli, S.J., and C.S. Lantz. 1999. Fundamental Immunology. Lippincott, Philadelphia. 1127 pp.
29. + αβ T cells activated by IL 12 as a major effecter in inhibition of experimental tumor metastasis. J. Immunol. 156:3366-3373.
30. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for V α14 NKT cells in IL-12-mediated rejection oftumors. Science. 278:1623-1626.
31. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand α galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1121-1128.
32. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et al. 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated V α 14 natural killer T cells. J. Exp. Med. 190:783-792.
33. Bendelac, A., R.D. Hunziker, and O. Lantz. 1996. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184:1285-1293.
34. + T cells with a transgenic variant TCR. J. Immunol. 165:168-174.
35. Leite-De-Moraes, M.C., A. Hameg, M. Pacilio, Y. Koezuka, M. Taniguchi, L. Van Kaer, E. Schneider, M. Dy, and A. Herbelin. 2001. IL-18 enhances IL-4 production by ligand activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 166:945-951.